TSK GYPROC
ActiveSummary
The computed 12-month bankruptcy probability of TSK GYPROC is 2.1% (moderate). The 2024 annual accounts show equity of €271,750 and a net result of €21,932. Equity is growing by ~10.2% per year across the filed fiscal years. Its solvency ranks better than 56% of 36400 sector peers (fiscal year 2024). The company has been active since 2014 and the Belgian State Gazette contains no insolvency or warning signals.
History
Acts, filings and financial milestones
2025
28-08
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema · 28 days late
2024
30-09
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 61 days late
2023
29-09
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 60 days late
2022
31-12
Financial
Highest result since 2018net €32,375 ▲61.2%
Operating result €44,115, net result €32,375, both a record.
14-10
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema · 75 days late
2021
31-12
Financial
Equity above €200,000Eq €201,737 ▲11.1%
4 profitable years in a row build equity to €201,737.
29-09
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema · 60 days late
2020
31-12
Financial
Weakest financial yearnet €14,560 ▼28.4%
Net result drops to €14,560, the lowest in the series; recovery starts the following year.
11-11
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema · 103 days late
2019
31-12
Financial
Equity above €150,000Eq €167,734 ▲13.3%
2 profitable years in a row build equity to €167,734.
24-09
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema · 55 days late
2018
27-08
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema · 27 days late
2017
16-08
NBB filing
Annual accounts filed
fiscal year 2016 · micro schema · 16 days late
2016
07-07
NBB filing
Annual accounts filed
fiscal year 2015 · full schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 5 acts read
About the unread acts
We know of 5 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.